跳至主要内容
临床试验/NCT07322666
NCT07322666已完成不适用

Tissue Repair of Incisions for Biopsy and Mouth Ulcers Using Non-Thermal Plasma

National Institute of Nuclear Research - Mexico1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年2月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Feasibility - Patient recruitment rate

研究概览

简要总结

The goal of this clinical trial (pilot study) is to evaluate the feasibility and preliminary effectiveness of Non-Thermal Plasma (NTP) in treating pain and accelerating healing in 50 patients with Recurrent Oral Ulcers (ROUs). The main questions it aims to answer are:

Is the study design feasible for a future large-scale trial?

Does NTP show promising preliminary results in reducing ulcer size and healing time compared to standard laser therapy and placebo?

Does NTP provide superior pain relief compared to standard laser therapy and placebo?

Researchers will compare the NTP group (n=20) to the Low-Level Laser Therapy (LLLT) group (n=20) and the placebo group (n=10) to see if NTP is more effective in accelerating healing and reducing pain.

Participants will:

Be randomly assigned to one of three treatment groups (NTP, LLLT, or placebo).

Receive their assigned treatment for their oral ulcers.

Undergo measurements of their ulcer size, report their pain perception using a visual analog scale (VAS), and have their time to complete healing recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 years of age
  • Patients of both sexes
  • Patients with recurrent oral ulcers (ROU)
  • Patients without oral soft tissue diseases
  • Patients with at least one recurrent ulcer

排除标准

  • Patients under 18 years of age
  • Patients with ROU of more than 48 hours' duration
  • Patients with gingivitis and/or periodontitis
  • Patients undergoing maxillofacial orthopedic and/or orthodontic treatment
  • Patients with ill-fitting dentures

结局指标

主要结局

Feasibility - Patient recruitment rate

时间窗: From the start of enrollment to the end of the recruitment period, an average of 1 month.

Proportion of the target sample size successfully recruited within the recruitment period. Unit of Measure: Percentage (%)

Feasibility - Patient adherence to the intervention protocol

时间窗: From the first intervention to the last planned session for each participant.

Proportion of prescribed treatment sessions completed by enrolled participants. Unit of Measure: Percentage (%)

Preliminary efficacy - Time to complete ulcer re-epithelialization

时间窗: From baseline (day of intervention) until complete healing, assessed daily up to 30 days.

Number of days required for the ulcer to achieve complete re-epithelialization (visual absence of ulcer crater) confirmed by clinical examination. Unit of Measure: Days

Preliminary efficacy - Change in pain intensity measured by a Visual Analogue Scale (VAS)

时间窗: From baseline (pre-intervention) to 48 hours post-intervention

The Visual Analogue Scale (VAS) is a 0 to 10 scale, where "0" represents "no pain" and "10" represents "the worst pain". A higher score indicates worse pain. The change score (post-intervention minus baseline) will be calculated. Unit of Measure: 0-10 VAS

次要结局

  • Change in ulcer surface area(From baseline (day of intervention) to days 1, 2, 3, 5, and 7 post-intervention)
  • Safety - Incidence and severity of treatment-related adverse events(From the first intervention until the end of the follow-up period (up to 7 days post-intervention))
  • Cumulative use of rescue analgesic medication(From baseline to complete healing or up to 30 days, whichever comes first)

研究者

发起方
National Institute of Nuclear Research - Mexico
申办方类型
Other
责任方
Principal Investigator
主要研究者

Benjamín Gonzalo Rodríguez Méndez

Professional B, Level 19

National Institute of Nuclear Research - Mexico

研究点 (1)

Loading locations...

相似试验